Publications by authors named "Arthur Kim"

Claim this Profile
R
Retreatment of Hepatitis C Virus Among People Who Inject Drugs.
Aurielle M Thomas, Alain H Litwin, Judith I Tsui, Sophie Sprecht-Walsh, Kendra L Blalock, Kimberly Page, Arthur Y Kim

Clin Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depression profiles and hepatitis C treatment outcomes among people who inject drugs: The HERO study.
Irene Pericot-Valverde, Snehal S Lopes, Jessica Obeysekare, Abigail W Batchelder, Megan Groome, Kimberly Page, Arthur Y Kim

J Psychosom Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technical systematic review supporting 2025 AASLD practice guidelines on management of chronic hepatitis B.
Calvin Q Pan, Samer Saadi, Marc G Ghany, Jordan J Feld, Joseph K Lim, Arthur Y Kim

Hepatology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AASLD/IDSA Practice Guideline on treatment of chronic hepatitis B.
Marc G Ghany, Calvin Q Pan, Anna S Lok, Jordan J Feld, Joseph K Lim, Arthur Y Kim

Hepatology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Envisioning a Multidisciplinary HBV Cure Research Agenda.
Karine Dubé, Ali Ahmed, Chari Cohen, Yasmin Ibrahim, George A Yendewa, Arthur Y Kim

Curr HIV/AIDS Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B Elimination in the US-Which Gaps Need to Be Closed?
Amir M Mohareb, Arthur Y Kim

JAMA Netw Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Continuation Versus Cessation of Antiviral Therapy in Chronic Hepatitis B: A Modelling Study With Implications for Hepatitis B Cure.
Amir M Mohareb, Ghideon Ezaz, Arthur Y Kim, Kenneth A Freedberg, Anders Boyd

J Viral Hepat· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Abatacept.
Nandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, Kathleen Chiotos, Amy L Dzierba, Arthur Y Kim

Clin Infect Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness.
Adarsh Bhimraj, Yngve Falck-Ytter, Lindsey R Baden, Roger Bedimo, Kelly Cawcutt, Arthur Y Kim

Clin Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Infliximab.
Nandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, Kathleen Chiotos, Amy L Dzierba, Arthur Y Kim

Clin Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct-Acting Antiviral Initiation Among People With Hepatitis C Virus (HCV) and HIV on Antiretroviral Therapy in the United States and Canada: Factors Driving the HCV Treatment Gap.
Raynell Lang, Elizabeth Humes, Asya Lyass, Leila H Borowsky, Brenna Hogan, Arthur Kim, H Nina Kim

Open Forum Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated phenotypic screening and chemical proteomics identifies ETF1 ligands that modulate viral translation and replication.
Arthur S Kim, Kevin Ma, Christopher J Reinhardt, Daniel C Lazar, Daisuke Ogasawara

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interest in Injectable and Oral PrEP for HIV Prevention Among Women and Men Who Inject Drugs.
Elenore P Bhatraju, Judith I Tsui, Moonseong Heo, Laksika B Sivaraj, Snehal S Lopes, Arthur Kim, Kimberly A Page

J Addict Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HKU5 bat merbecoviruses engage bat and mink ACE2 as entry receptors.
Mia Madel Alfajaro, Emma L Keeler, Ning Li, Nicholas J Catanzaro, I-Ting Teng, Arthur S Kim

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C.
Arthur Y Kim, Minhee Kang, Triin Umbleja, Estevão P Nunes, Kristen M Marks

Clin Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Self-reported Pain Before and After Cure of Hepatitis C Among Persons Who Actively Inject Drugs.
Judith I Tsui, Natasha T Ludwig-Barron, Jocelyn R James, Moonseong Heo, Laksika B Sivaraj, Arthur Y Kim, Kimberly Page

J Addict Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in anxiety symptoms during treatment of Hepatitis C in people who inject drugs: The HERO study.
Jessica Obeysekare, Irene Pericot-Valverde, Snehal Lopes, Megan Groome, Brianna L Norton, Arthur Y Kim, Kimberly Page

Drug Alcohol Depend· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-navigator working alliance and hepatitis C treatment cascade outcomes among persons who inject drugs: The HERO study.
Snehal S Lopes, J Edward Dotherow, Irene Pericot-Valverde, Paula J Lum, Lynn E Taylor, Arthur Y Kim, Kimberly Page

Drug Alcohol Depend· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab.
Nandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, Kathleen Chiotos, Amy L Dzierba, Arthur Y Kim

Clin Infect Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe outcomes of COVID-19 among adults with increased risk conditions: A population-based observational study.
Scott Dryden-Peterson, Andy Kim, Ellen C Caniglia, Mary-Ruth Joyce, David Rubins, Arthur Y Kim

PLoS One· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Statin Use Appears to Protect Against Severe COVID-19.
Eric A Meyerowitz, Arthur Y Kim

Open Forum Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned.
Roy M Gulick, Alice K Pau, Eric Daar, Laura Evans, Rajesh T Gandhi, Arthur Kim

Ann Intern Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis.
Adarsh Bhimraj, Yngve Falck-Ytter, Arthur Y Kim, Jonathan Z Li, Lindsey R Baden

Clin Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO Study.
Snehal S Lopes, Moonseong Heo, Irene Pericot-Valverde, Brianna L Norton, Lynn E Taylor, Arthur Y Kim, Kimberly Page

Viruses· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of pegivirus persistence, cross-species infection, and adaptation in the laboratory mouse.
Kylie Nennig, Satyapramod Murthy, Sara Maloney, Teressa M Shaw, Mark Sharobim, Arthur S Kim

PLoS Pathog· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis